Playing Nice Over REMS: FDA Sees Accutane As Model For Shared Systems

FDA will use the Accutane risk management agreement between Roche and generic drug companies as a guide for implementing the Risk Evaluation & Mitigation Strategy "shared use" provision of the FDA Amendments Act